Neuropsychology in Cameroon: first normative data for cognitive tests among school-aged children

N Ruffieux1, A K Njamnshi, E Mayer

  • 1Faculty of Psychology and Educational Sciences, Geneva University, and Department of Neurology, Geneva University Hospital and Medical School, Switzerland. Nicolas.Ruffieux@unige.ch

Insights

This study provides the first normative data for neuropsychological tests in Cameroonian children, crucial for assessing cognitive function and aiding in the detection of sickle cell disease complications.

Area of Science:

  • Neuropsychology
  • Cognitive Science
  • Pediatrics

Background:

  • Limited availability of psychometric test normative data in sub-Saharan Africa.
  • Identified need for psychological and neuropsychological assessments in Cameroon.
  • Project aims to evaluate cognitive function in Cameroonian children with Sickle Cell Disease.

Purpose of the Study:

  • Establish normative data for psychometric tests adapted to the Cameroonian cultural context.
  • Assess cognitive functioning in Cameroonian school-aged children.
  • Develop culturally appropriate tools for neuropsychological evaluation.

Main Methods:

  • Recruited 125 healthy Cameroonian school-aged children from Yaounde.
  • Administered a battery of 14 cognitive tests focusing on executive functions and memory.
  • Selected tests based on simplicity, low verbal demand, and cross-cultural applicability.

Main Results:

  • The cognitive test battery is suitable for neuropsychological evaluation in Cameroon.
  • The Block Design test (WISC-IV) and a Verbal Phonemic Fluency test were less appropriate.
  • Factor analysis supported a four-factor model consistent with expected cognitive measures.
  • Analyzed effects of gender, age, and education on test performance.

Conclusions:

  • This study presents the first normative data for neuropsychological tests in Cameroonian children.
  • Represents a significant step for advancing neuropsychology in Cameroon and sub-Saharan Africa.
  • The established battery is utilized to detect cerebrovascular complications in children with Sickle Cell Disease.
Abstract